New User Account Set Up

If you do not have an account with the Digest, please click on "Submit to the Digest." By logging in with your UCLA Login ID (formerly known as BOL Login), a new account will automatically be generated. If you experience any difficulties, please send an email to our help desk: drc-support@ctrl.ucla.edu.

Questions

If you have any questions or concerns, please email our help desk/support team: drc-support@ctrl.ucla.edu. We are more than happy to address any questions or concerns regarding the Weekly Message Digest system you may have.

How do I subscribe?

If you have a mednet email account (@mednet.ucla.edu), you should already be subscribed.

If you do not have a mednet email account or you are not receiving the Digest, please send an email to drc-support@ctrl.ucla.edu and we will add you to our list.

Depressed Volunteers Needed for Ketamine Treatment Study

DGSOM WMD twitter logo

If you are experiencing moderate-to-severe depression for at least six months, meet criteria for treatment resistance, and are between 20-64 years old, you may be eligible to participate in a ketamine infusion treatment study at UCLA. 

  • Our study is looking at how ketamine treatment relates to changes in mood, brain chemistry and function, and gene regulation.
  • The study involves screening tests to determine eligibility, receiving up to 4 ketamine infusions at UCLA, and having 4 brain scans (1 scan before treatment, 1 scan the day after the first treatment, 1 scan the day after the last treatment, and approximately 5 weeks after treatment completion)
  • Blood samples will be collected to examine gene regulation and immune system response before each brain scan
  • This study involves logging mood regularly on your phone during and after treatment
  • Patients must be diagnosed with depression, able to undergo MRI scanning, and not be using illicit substances. A letter from your treating psychiatrist is required. 
  • The procedures will be at no cost to you and will occur over a 2-week period with the entire study lasting up to 2 months. Transporation will be reimbursed
  • A letter from your current psychiatrist authorizing participation in the study is required

Please call 310-794-0305 or e-mail DGCBiomarkerStudy@mednet.ucla.edu   to speak to the Ketamine Study Coordinator.

 

Protocol ID: IRB#15-001173    UCLA IRB Approved   Approval Date: 6/8/2017   Through: 6/7/2018   Committee: Medical IRB 3

Posting Information
This posting expired on August 01, 2017.
Posting Attachment: Download Attachment

Share this posting on social media!